HC Wainwright & Co. Maintains Buy on Oculis Holding, Raises Price Target to $39

9/18/2026
Impact: 85
Healthcare

HC Wainwright & Co. analyst Yi Chen has maintained a 'Buy' rating on Oculis Holding (NASDAQ: OCS) and increased the price target from $26 to $39. This adjustment reflects a positive outlook for the company's stock performance.

AI summary, not financial advice

Share: